Scintigraphic and Radiologic Features of Erdheim-Chester Disease: A Case Report

Case Report

Austin J Nucl Med Radiother. 2014;1(2): 2.

Scintigraphic and Radiologic Features of Erdheim-Chester Disease: A Case Report

Miguel Hernandez Pampaloni* and Evan Sirc

Department of Radiology and Biomedical Imaging, University of California, USA

*Corresponding author: Miguel Hernandez Pampaloni, Department of Radiology and Biomedical Imaging, University of California, 505 Parnassus Avenue, M-396, San Francisco, CA, 94143, USA

Received: October 30, 2014; Accepted: December 05, 2014; Published: December 08, 2014

Abstract

Erdheim-Chester disease is a rare, non-Langerhans histiocytosis with a highly variable set of systemic manifestations. The disease affects a wide range of ages with a slight male predominance. Radiologically, skeletal abnormalities are most common, including bilateral, symmetric osteosclerosis in the diaphyses of long bones. Imaging of the face can show an extensive retroorbital soft tissue masses. While the anatomic imaging characteristics of Erdheim-Chester have been well-described in previous publications, much less has been reported regarding the scintigraphic manifestations of the disease. This report describes an interesting case with dramatic bone scan and whole-body F-18 FDG PET abnormalities which are correlated with findings on abdominal CT and chest MRI. Erdheim-Chester disease is a rare, non-Langerhans histiocytosis with a highly variable set of systemic manifestations.

Keywords: Scintigraphic; Erdheim-chester disease; Osteosclerosis; Histiocytosis

Case Report

Erdheim-Chester Disease (ECD) is a rare form of non Langerhans' cell histiocytosis. Individuals affected by this disease are typically adults between their 5th and 7th decades of life. The multi systemic form of ECD is associated with significant morbidity, which may arise due to histiocytic infiltration of critical organ systems. The most common presenting symptom of ECD is bone pain. The etiology of ECD is unknown yet thought to be associated with an intense immune response. Bilateral symmetric increased tracer uptake on 99mTc bone scintigraphy affecting the periarticular regions of the long bones is highly suggestive of ECD [1]. However, definite diagnosis of ECD is established only once CD68(+), CD1a(-) histiocytes are identified within a biopsy specimen Clinically, patients may present with bone pain, diabetes insipidus, exophthalmos, neurological signs, and xanthomas, as well as non-specific general symptoms such as fever, weight loss, and weakness. Given its rarity, it is diagnostically elusive and requires a high level of clinical suspicion. Therapeutically, it is of limited alternatives. Currently, interferon-alpha is the most extensively studied agent in the treatment of ECD and serves as the first line of treatment. Treatment with other agents is based on anecdotal case reports and on the basis of biological rationale.